Company: ZCARW
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001013762-25-003498
Chunk: 113

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-28
Form: DRS
Chunk 113
---
 resale of all Registrable Securities, (ii)
the date on which the holder of a Series B Warrant, for ten (10) consecutive trading days, can sell all Registrable Securities pursuant
to Rule 144 without restriction or limitation or (iii) 12 months and ten trading days immediately following issuance of the Series B Warrants.
Since none of the Registrable Securities issued in connection with the December 2024 Offering or the January/February Offering are currently
registered for resale under an effective registration statement, the Reset Date, with respect to the Series B Warrants issued in the December
2024 Offering and January/February Offering, has not yet been triggered. Notwithstanding, the Board has resolved to grant the holders
of such Series B Warrants the right for them to deem the Reset Date to have been triggered using the Floor Price of $6.24 in lieu of the
applicable VWAP, to determine the number of shares available for exercise under such Series B Warrants. Because it may be argued that
these Series B Warrants are not yet exercisable and the issuance of the shares of Common Stock could have a dilutive effect on all of
our other stockholders, there is a risk that we could be subject to claims and potential litigation by our stockholders and any damages
we could suffer could have a material adverse effect on our financial situation and operations.

<div align='center'>57

USE OF PROCEEDS</div>

We estimate that from the
gross proceeds of $25,000,000 raised in this offering, assuming no exercise of the over-allotment option by the underwriter, the net proceeds
from this offering will be approximately $ , after deducting the estimated
underwriting discounts and estimated offering expenses payable by us, based on an assumed public offering price of $
per unit. If the over-allotment option for common shares (or Pre-Funded Warrants) is exercised in full, we estimate that our net proceeds
will be approximately $ , after deducting the underwriting discount and estimated offering
expenses payable by us. We intend to use the net proceeds from this offering for working capital and general corporate purposes.

A $1.00 increase or decrease
in the assumed public offering price of $ per Unit would increase or decrease
the net proceeds from this offering by approximately $ , assuming that the
number of units offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting
discounts